RNA interference |
11.0% |
stem cell proliferation |
10.1% |
gene silencing |
12.1% |
innate immune response |
13.0% |
segmentation |
10.1% |
inflammatory cell apoptosis |
10.3% |
neurogenesis |
12.3% |
neuroprotection |
11.2% |
mesenchymal cell development |
10.2% |
protein ubiquitination |
13.2% |
autophagy |
22.5% |
histone acetylation |
10.7% |
mesenchymal cell proliferation |
14.2% |
histone methylation |
14.1% |
stem cell maintenance |
13.0% |
adaptive immune response |
14.1% |
chromatin remodeling |
11.6% |
chromatin silencing |
10.8% |
histone modification |
13.2% |
microglial cell activation |
10.8% |
chromatin modification |
11.4% |
triglyceride homeostasis |
10.7% |
histone lysine methylation |
13.7% |
DNA demethylation |
11.6% |
transdifferentiation |
10.4% |
Notch signaling pathway |
14.2% |
histone H3 acetylation |
11.8% |
cell redox homeostasis |
10.4% |
chromatin maintenance |
12.3% |
Toll signaling pathway |
13.5% |
chromatin assembly or disassembly |
11.6% |
mesenchymal cell apoptosis |
15.4% |
toll-like receptor signaling pathway |
13.7% |
endoplasmic reticulum unfolded protein response |
17.0% |
nucleosome assembly |
10.4% |
post-translational protein acetylation |
11.0% |
lymphangiogenesis |
13.8% |
protein sumoylation |
13.4% |
autophagic cell death |
16.5% |
vascular endothelial growth factor receptor signaling pathway |
11.0% |
BMP signaling pathway |
12.0% |
toll-like receptor 1 signaling pathway |
13.4% |
store-operated calcium entry |
10.0% |
sprouting angiogenesis |
12.8% |
Wnt receptor signaling pathway |
14.6% |
toll-like receptor 4 signaling pathway |
13.9% |
pre-miRNA processing |
20.1% |
toll-like receptor 2 signaling pathway |
13.2% |
anti-apoptosis |
11.8% |
catabolic process |
10.7% |
mitochondrial fission |
15.8% |
kinetochore assembly |
12.6% |
toll-like receptor 3 signaling pathway |
13.1% |
anoikis |
12.8% |
neural precursor cell proliferation |
10.5% |
cell fate commitment |
11.1% |
nucleosome positioning |
10.5% |
protein polyubiquitination |
13.7% |
peroxisome proliferator activated receptor signaling pathway |
10.9% |
androgen receptor signaling pathway |
11.8% |
nucleosome disassembly |
13.5% |
protein catabolic process |
10.3% |
macroautophagy |
17.7% |
histone ubiquitination |
17.9% |
myeloid cell homeostasis |
13.7% |
nitric oxide storage |
10.8% |
heterochromatin assembly |
11.3% |
tendon cell differentiation |
10.4% |
germ-line stem cell maintenance |
14.4% |
T-helper 17 cell differentiation |
20.2% |
cilium assembly |
12.7% |
progesterone receptor signaling pathway |
11.2% |
protein glutathionylation |
16.6% |
toll-like receptor 7 signaling pathway |
13.1% |
protein monoubiquitination |
16.3% |
protein lipidation |
12.0% |
chronological cell aging |
11.8% |
toll-like receptor 9 signaling pathway |
12.8% |
smoothened signaling pathway |
15.8% |
somatic stem cell maintenance |
17.6% |
virus-host interaction |
11.5% |
neuronal stem cell maintenance |
11.7% |
canonical Wnt receptor signaling pathway |
17.0% |
protein deubiquitination |
11.6% |
reactive oxygen species metabolic process |
10.9% |
neuroblast proliferation |
12.3% |
protein lipoylation |
15.2% |
kinetochore organization |
10.3% |
natural killer cell degranulation |
16.3% |
mitochondrial respiratory chain complex assembly |
11.5% |
response to endoplasmic reticulum stress |
13.7% |
dendritic spine morphogenesis |
15.8% |
primary miRNA processing |
21.1% |
superior temporal gyrus development |
16.4% |
glycerol metabolic process |
11.2% |
microtubule severing |
11.8% |
oncogene-induced senescence |
22.9% |
MyD88-dependent toll-like receptor signaling pathway |
13.5% |
stress-induced premature senescence |
10.0% |
extracellular matrix disassembly |
11.5% |
organic acid metabolic process |
11.0% |
cellular response to cold |
10.4% |
histone H2A ubiquitination |
14.6% |
histone H2B ubiquitination |
15.3% |
protein neddylation |
15.9% |
response to unfolded protein |
14.5% |
succinate metabolic process |
11.3% |
ribosomal small subunit biogenesis |
10.9% |
ephrin receptor signaling pathway |
11.3% |
cell-cell junction organization |
11.0% |
synaptic vesicle clustering |
10.2% |
flavonoid metabolic process |
10.2% |
multivesicular body sorting pathway |
12.8% |
axon cargo transport |
10.5% |
neural crest cell fate specification |
12.8% |
MyD88-independent toll-like receptor signaling pathway |
11.0% |
stress granule assembly |
21.7% |
protein K63-linked ubiquitination |
21.0% |
posterior head segmentation |
11.5% |
common myeloid progenitor cell proliferation |
10.7% |
protein autoubiquitination |
13.9% |
T-helper cell lineage commitment |
13.4% |
heme export |
10.3% |
oxidative DNA demethylation |
15.2% |
interkinetic nuclear migration |
13.0% |
DNA catabolic process |
10.0% |
oxidative stress-induced premature senescence |
11.2% |
histone monoubiquitination |
26.7% |
base-excision repair, DNA ligation |
13.1% |
peroxisome fission |
17.1% |
Golgi ribbon formation |
13.4% |
RNA catabolic process |
12.2% |
protein desumoylation |
12.5% |
response to misfolded protein |
21.1% |
epithelial to mesenchymal transition |
24.3% |
mesenchymal to epithelial transition |
24.3% |
intein-mediated protein splicing |
11.0% |
zinc ion transmembrane transport |
11.0% |
anatomical structure regression |
12.5% |
cellular response to misfolded protein |
19.7% |
protein deglutathionylation |
18.3% |
medium-chain fatty acid biosynthetic process |
14.3% |
G2/M transition DNA damage checkpoint |
11.4% |
protein targeting to plasma membrane |
11.4% |
urate metabolic process |
13.0% |
heme metabolic process |
10.3% |
telomere maintenance via telomerase |
11.9% |
proteasome regulatory particle assembly |
22.7% |
signalosome assembly |
10.6% |
collagen catabolic process |
16.1% |
embryonic pectoral fin morphogenesis |
11.5% |
mRNA catabolic process |
13.6% |
T-helper 1 cell lineage commitment |
15.8% |
hepatoblast differentiation |
12.5% |
glial cell fate commitment |
10.7% |
cullin deneddylation |
10.9% |
proepicardium development |
16.7% |
mitochondrial respiratory chain complex II assembly |
16.7% |
neuromast development |
11.3% |
valine metabolic process |
13.5% |
formate metabolic process |
11.5% |
Wnt receptor signaling pathway, planar cell polarity pathway |
20.0% |
age-dependent telomere shortening |
16.0% |
sinoatrial node cell differentiation |
14.0% |
histone deubiquitination |
12.0% |
double-strand break repair via nonhomologous end joining |
10.0% |
replication fork protection |
24.5% |
Roundabout signaling pathway |
14.3% |
vitamin K metabolic process |
12.2% |
butyrate metabolic process |
12.2% |
protein homooligomerization |
10.2% |
septin ring assembly |
14.6% |
cytosol to ER transport |
10.4% |
hippo signaling cascade |
36.2% |
membrane to membrane docking |
12.8% |
piRNA metabolic process |
13.0% |
polyphosphate metabolic process |
10.9% |
non-canonical Wnt receptor signaling pathway |
27.3% |
CD24 biosynthetic process |
15.9% |
mitochondrial protein catabolic process |
15.9% |
ATP catabolic process |
11.4% |
fumarate metabolic process |
11.4% |
central nervous system vasculogenesis |
11.6% |
protein K48-linked ubiquitination |
14.3% |
short-chain fatty acid metabolic process |
22.0% |
L-serine catabolic process |
19.5% |
cell surface pattern recognition receptor signaling pathway |
10.0% |
thermosensory behavior |
15.4% |
sister chromatid biorientation |
21.1% |
protein targeting to lysosome |
10.5% |
oxaloacetate metabolic process |
10.8% |
multicellular organismal development |
19.4% |
T-tubule organization |
17.1% |
protein localization to synapse |
11.8% |
leptin-mediated signaling pathway |
12.1% |
telomere maintenance via recombination |
12.5% |
circadian sleep/wake cycle, REM sleep |
12.5% |
helper T cell extravasation |
12.5% |
stress granule disassembly |
16.7% |
corticospinal tract morphogenesis |
13.3% |
nucleotide-excision repair, DNA gap filling |
10.0% |
syncytial blastoderm mitotic cell cycle |
10.0% |
copper ion import |
10.0% |
endoplasmic reticulum tubular network organization |
13.8% |
histone H4-K16 acetylation |
13.8% |
isoleucine metabolic process |
17.9% |
cytoplasmic mRNA processing body assembly |
18.5% |
histone H2A monoubiquitination |
19.2% |
myelination in peripheral nervous system |
19.2% |
low-density lipoprotein particle remodeling |
11.5% |
T-helper 17 cell chemotaxis |
20.0% |
astrocyte fate commitment |
16.0% |
plasma membrane to endosome transport |
12.0% |
dendrite self-avoidance |
34.8% |
retrograde axon cargo transport |
17.4% |
telomere maintenance via telomere shortening |
13.6% |
UDP-glucose metabolic process |
20.0% |
retrograde transport, endosome to Golgi |
10.0% |
transposition, DNA-mediated |
10.0% |
endosomal lumen acidification |
21.1% |
PML body organization |
10.5% |
cloacal septation |
10.5% |
glutamine catabolic process |
10.5% |
one-carbon metabolic process |
22.2% |
interleukin-6-mediated signaling pathway |
22.2% |
histone H3-S10 phosphorylation |
22.2% |
phytol metabolic process |
11.1% |
pyridoxal 5-phosphate salvage |
11.1% |
tumor necrosis factor-mediated signaling pathway |
17.6% |
receptor localization to synapse |
11.8% |
glycolate metabolic process |
11.8% |
cellular response to glucose starvation |
12.5% |
estrogen catabolic process |
12.5% |
lysosomal lumen acidification |
26.7% |
heparan sulfate proteoglycan metabolic process |
13.3% |
histone H4-K5 acetylation |
13.3% |
oligodendrocyte cell fate commitment |
13.3% |
lipopolysaccharide-mediated signaling pathway |
28.6% |
sphingolipid catabolic process |
21.4% |
branchiomeric skeletal muscle development |
14.3% |
cellular response to insulin stimulus |
14.3% |
aggresome assembly |
14.3% |
nucleotide-excision repair, DNA duplex unwinding |
14.3% |
ferrous iron import |
30.8% |
M phase specific microtubule process |
15.4% |
fructose catabolic process |
16.7% |
ruffle assembly |
16.7% |
lymphocyte chemotaxis across high endothelial venule |
16.7% |
glycosphingolipid catabolic process |
16.7% |
iridophore differentiation |
18.2% |
early endosome to late endosome transport |
18.2% |
multicellular organismal aging |
50.0% |
lysine catabolic process |
40.0% |
glucosamine catabolic process |
30.0% |
nucleotide-binding oligomerization domain containing signaling pathway |
20.0% |
water-soluble vitamin metabolic process |
10.0% |
protein folding in endoplasmic reticulum |
10.0% |
succinyl-CoA metabolic process |
10.0% |
phytoalexin metabolic process |
10.0% |
protein localization in mitochondrion |
10.0% |
nitric oxide production involved in inflammatory response |
10.0% |
response to UV-C |
11.1% |
nucleotide-excision repair, DNA incision, 3-to lesion |
11.1% |
ventral spinal cord interneuron fate determination |
11.1% |
exogenous drug catabolic process |
11.1% |
protein heterotetramerization |
11.1% |
very-low-density lipoprotein particle remodeling |
11.1% |
embryonic process involved in female pregnancy |
11.1% |
oenocyte development |
11.1% |
protein K11-linked ubiquitination |
50.0% |
protein linear polyubiquitination |
37.5% |
paranodal junction assembly |
12.5% |
alternative nuclear mRNA splicing, via spliceosome |
12.5% |
glycerol ether metabolic process |
12.5% |
low-density lipoprotein particle mediated signaling |
12.5% |
adiponectin-mediated signaling pathway |
12.5% |
eye pigment granule organization |
12.5% |
posterior lateral line neuromast primordium migration |
12.5% |
COPII vesicle coating |
42.9% |
nucleotide-binding oligomerization domain containing 2 signaling pathway |
28.6% |
intermediate filament bundle assembly |
28.6% |
glucose 1-phosphate metabolic process |
14.3% |
deoxyribonucleoside catabolic process |
14.3% |
branched chain family amino acid biosynthetic process |
14.3% |
de novo cotranslational protein folding |
14.3% |
inositol phosphate-mediated signaling |
14.3% |
immunoglobulin production in mucosal tissue |
14.3% |
histone mRNA metabolic process |
50.0% |
age-dependent response to reactive oxygen species |
33.3% |
defense response to nematode |
33.3% |
leukocyte migration involved in immune response |
16.7% |
polar body extrusion after meiotic divisions |
16.7% |
mitochondrial fragmentation involved in apoptosis |
16.7% |
dermatan sulfate proteoglycan metabolic process |
16.7% |
Wnt receptor signaling pathway, calcium modulating pathway |
60.0% |
plus-end-directed vesicle transport along microtubule |
40.0% |
embryonic olfactory bulb interneuron precursor migration |
20.0% |
diacylglycerol catabolic process |
20.0% |
cysteine biosynthetic process via cystathionine |
20.0% |
nucleoside triphosphate catabolic process |
20.0% |
semaphorin-plexin signaling pathway |
20.0% |
keratan sulfate metabolic process |
20.0% |
nucleotide-sugar metabolic process |
50.0% |
flavone metabolic process |
50.0% |
I-kappaB kinase/NF-kappaB cascade |
25.0% |
phosphatidylinositol-mediated signaling |
25.0% |
response to organic cyclic compound |
25.0% |
3-UTR-mediated mRNA stabilization |
25.0% |
barrier septum assembly |
25.0% |
cell-substrate junction assembly |
25.0% |
anthranilate metabolic process |
25.0% |
RNA splicing, via transesterification reactions |
25.0% |